Post-Conference Perspectives: Advances in the Management of Newly Diagnosed Ph+ Acute Lymphoblastic Leukemia : Episode 2
Evolving Standard of Care for Patients Diagnosed with Ph+ ALL
Drs Aldoss and Przespolewski evaluate the changing treatment landscape for patients diagnosed with Ph+ ALL.
EP: 1.Defining and Diagnosing Philadelphia Chromosome-Positive (Ph+) ALL
Now Viewing
EP: 2.Evolving Standard of Care for Patients Diagnosed with Ph+ ALL
EP: 3.Recent Updates from the PhALLCON Study
EP: 4.Ponatinib and Blinatumomab Use in Patients with Newly Diagnosed Ph+ ALL
EP: 5.Notable Advancements in Treatment for ALL
EP: 6.Unmet Needs and Treatment Trajectory for Patients Diagnosed with Ph+ ALL
Related Videos
Related Content
